Neurocrine Biosciences In...

113.11
-0.89 (-0.78%)
At close: Mar 28, 2025, 3:59 PM

Neurocrine Biosciences Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96
Cash & Equivalents 233M 251.1M 262.9M 340.8M 801M 112.28M 141.71M 254.71M 83.27M 74.19M 31.01M 44.79M 63.75M 50.11M 54.05M 37.33M 68.47M 99.66M 80.98M 49.95M 61.03M 105.85M 44.31M 163.89M 21.08M 21.3M 11.7M 15.8M 11.3M
Short-Term Investments 843.1M 780.5M 726.4M 370.5M 613.9M 558.25M 509.2M 261.22M 224.08M 305M 162.79M 100.95M 109.26M 79M 72.81M 16.14M 12.01M 79.72M 101.62M 223.12M 240.1M 347.31M 200.4M 156.09M 143.59M 69.8M n/a n/a n/a
Long-Term Investments 124.8M 849.4M 401.5M 624.4M 265.3M 355.6M 216.03M 247.36M 43.49M 82.49M 37.49M n/a 480K -343.7M 3.74M 6.41M 21.06M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 755M 49.6M 25M 4.4M 6.4M 3.2M 5.48M 4.5M 4.88M 4.79M 4.83M 4.44M 4.33M 4.31M 6.1M -78.97M 9.51M 11.11M 104.64M 104.51M 103.24M 26.91M 4.34M 2.56M 1.9M 2.6M 3M 5.5M 1M
Receivables 479.1M 439.3M 350M 185.5M 157.1M 126.58M 56.24M 31.13M n/a n/a n/a 23K 14.09M 1.9M 4.47M n/a 39K 27K 7.19M 858K 8.21M n/a n/a 9.95M 5.97M 1.5M 1.4M 200K 1.3M
Inventory 57.4M 38.3M 35.1M 30.5M 28M 17.29M 10.86M -31.13M n/a n/a n/a -23K -14.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 112.1M 97.8M 79.1M 45.5M 30.1M 16.64M 19.76M 7.86M 3.09M 4.88M 4.39M 2.72M 2.16M 1.47M 1.72M 623K 911K 3.54M 3.86M 5.38M 4.47M 18.64M 3.38M 1.58M 1.76M 2.2M 52.5M 60.4M 59.5M
Total Current Assets 1.72B 1.61B 1.45B 972.8M 1.02B 831M 737.78M 554.92M 310.44M 384.07M 198.2M 148.46M 189.26M 132.48M 133.05M 55.39M 81.42M 182.95M 193.66M 279.31M 313.81M 471.81M 248.09M 331.51M 172.41M 94.8M 65.6M 76.4M 72.1M
Property-Plant & Equipment 592M 347.3M 145.6M 155.8M 127.4M 116.2M 33.87M 10.81M 6.27M 3.43M 2.51M 1.77M 1.9M 1.59M 1.53M 2.69M 6.19M 82.6M 91.38M 99.31M 102.17M 56.24M 14.1M 12.09M 11.3M 11.2M 10.9M 8.8M 3.5M
Goodwill & Intangibles 36.5M 35.5M 37.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 18.4M n/a 23.4M n/a n/a n/a n/a n/a n/a n/a 188K 362K 600K 1M 1.2M 1.4M
Total Long-Term Assets 1.99B 1.64B 915.2M 1.1B 718.5M 475M 255.37M 262.67M 54.64M 90.71M 44.83M 6.21M 6.71M 5.89M 11.37M 15.43M 36.76M 93.71M 196.02M 203.81M 205.4M 83.15M 18.45M 14.84M 13.56M 14.4M 14.9M 15.5M 5.9M
Total Assets 3.72B 3.25B 2.37B 2.07B 1.73B 1.31B 993.15M 817.59M 365.09M 474.79M 243.03M 154.68M 195.98M 138.37M 144.42M 70.82M 118.18M 276.65M 389.68M 483.12M 519.22M 554.96M 266.54M 346.35M 185.96M 109.2M 80.5M 91.9M 78M
Account Payables 110M 108.9M 67.3M 51.5M 39.4M 41.4M 13.8M 5.65M 5.08M 2.56M 246K 101K 911K 1.11M 810K 2.19M 1.6M 3.78M 3.21M 3.45M 5.39M 1.29M 1.96M 1.54M 1.06M 2.4M 2.5M 1.8M 800K
Deferred Revenue n/a n/a n/a -16.5M -10.3M -46.21M 10.23M 10.23M 10.23M 10.23M n/a n/a 2.92M 37.28M 39.98M 2.94M 2.94M 2.93M n/a 6.54M 27.67M 49.67M 5.7M 5.38M n/a n/a n/a n/a n/a
Short-Term Debt n/a 170.1M 169.4M n/a n/a 408.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.29M n/a 1.49M 4.49M -548K 6.67M 3.96M 2.66M 2.09M 1.59M 1M 800K 900K 800K
Other Current Liabilities 397.7M 351.4M 292M 194.3M 147.1M 115.1M 74.43M 48.05M 21.8M 19.46M 15.42M 11.6M 11.82M 46M 11.99M 7.68M 21.56M 21.72M 12.41M 17.89M 19.85M 55.09M 22.16M 15.75M 12.31M 5.2M 2.3M 4.7M 2.5M
Total Current Liabilities 507.7M 654.8M 537.7M 245.8M 186.5M 565.3M 88.23M 54.43M 30.41M 25.71M 15.66M 11.7M 15.65M 47.11M 52.78M 19.96M 26.09M 29.91M 20.12M 33.69M 59.59M 110.01M 32.48M 24.76M 14.96M 8.6M 5.6M 7.4M 4.1M
Long-Term Debt 455.1M 258.3M 93.5M 440.4M 412.3M 86.7M 388.5M 369.62M n/a n/a n/a n/a n/a n/a n/a 28.59M n/a n/a 49.15M 53.59M 59.45M 32.47M 5.28M 3.6M 2.28M 2.1M 2.2M 700K 800K
Other Long-Term Liabilities 166.2M 106.3M 29.7M 12.3M 9.7M 17.1M 35.66M 21.41M 19.8M 24.62M 18.67M 22.57M 25.96M 4.25M 8.09M 29.5M 10.77M 113.45M 5.69M 5.74M 4.35M 3.11M 3.7M 7.6M 5.51M 2.1M 700K 600K 300K
Total Long-Term Liabilities 621.3M 364.6M 123.2M 452.7M 422M 103.8M 424.15M 391.03M 19.8M 24.62M 18.67M 22.57M 25.96M 31.18M 72.3M 46.9M 55.31M 128.05M 54.84M 59.33M 65.81M 53.82M 9.81M 11.2M 7.79M 4.2M 2.9M 1.3M 1.1M
Total Liabilities 1.13B 1.02B 660.9M 698.5M 608.5M 669.1M 512.39M 445.45M 50.21M 50.33M 34.33M 34.27M 41.61M 78.29M 125.08M 66.86M 81.41M 157.96M 74.96M 93.02M 125.39M 163.84M 42.28M 35.96M 22.75M 12.8M 8.5M 8.7M 5.2M
Total Debt 455.1M 428.4M 262.9M 440.4M 412.3M 495.5M 388.5M 369.62M n/a n/a n/a n/a n/a n/a n/a 11.53M n/a 1.49M 53.64M 59.4M 66.13M 36.43M 7.93M 5.69M 3.87M 3.1M 3M 1.6M 1.6M
Common Stock 100K 100K 100K 100K 100K 92K 91K 89K 87K 86K 76K 67K 66K 55K 55K 44K 39K 38K 38K 37K 37K 35K 31K 30K 25K n/a n/a n/a n/a
Retained Earnings 29.2M -157.1M -406.8M -635.8M -725.4M -1.13B -1.18B -1.2B -1.06B -915.23M -826.3M -765.76M -719.67M -724.7M -762.27M -754.3M -703.26M -614.65M -407.35M -300.15M -277.95M -232.18M -201.93M -107.39M -70.48M -41.7M -24.9M -4.9M -10M
Comprehensive Income 5.8M 7M -7.9M -1.7M 1.8M 1.41M -1.93M -1.85M -318K -977K -277K 5K -2K -87K -48K 1.21M -1.57M -233K 99K -1.5M -2.29M 741K 2.06M -2.27M 98K -600K -4.2M -3M -2M
Shareholders Equity 2.59B 2.23B 1.71B 1.37B 1.13B 636.9M 480.76M 372.14M 314.88M 424.45M 208.7M 120.41M 154.37M 60.08M 19.34M 3.95M 36.77M 118.7M 314.72M 390.1M 393.83M 391.12M 224.25M 310.39M 163.21M 96.4M 72M 83.2M 72.8M
Total Investments 967.9M 1.63B 1.13B 994.9M 879.2M 913.85M 725.23M 508.58M 267.57M 387.48M 200.29M 100.95M 109.74M 79M 76.55M 22.55M 33.06M 79.72M 101.62M 223.12M 240.1M 347.31M 200.4M 156.09M 143.59M 69.8M n/a n/a n/a